AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife - AstraZeneca (NASDAQ:AZN), Bristol-Myers Squibb (NYSE:BMY)

Benzinga

Center

Factuality

Ownership

AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife - AstraZeneca (NASDAQ:AZN), Bristol-Myers Squibb (NYSE:BMY)

Despite the growing tension between China and the United States, worldwide pharmaceutical powerhouses are actively pursuing deals in China. The aim is to strengthen their drug pipelines and expand their presence in the world’s second-largest pharmaceutical market. What Happened: Several significant deals have been signed this year. Notably, AstraZeneca (NASDAQ:AZN) bought China-based cell therapy developer Gracell Biotechnologies for $1.2 billio…